Transatlantic deal would make ‘HSF Kramer’ a top 20 global firm by revenue | ‘Transformational’ combination a ‘one-of-a-kind’ ...

Vidal announced she will return to private sector after December departure | USPTO director told colleagues they had ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

Sapna Palla joins the firm in New York, bringing significant experience in complex life sciences and IP disputes to a growing ...

The patents have been officially revoked following the pair's voluntary decision to withdraw them | Withdrawal follows ...

22 October 2024 Association’s annual event is held in China for the first time I Vice premier of China, Zhang Guoqing, ...

18 February 2024 While President Biden’s desire to reduce costs at the pharmacy counter is commendable, it is too blunt an ...

A US biopharma firm must pay the damages to Sandoz over a long-running dispute over lung therapy | New Jersey district judge ...

A jury in Delaware unanimously dismissed all allegations of misappropriation against Inhibrx, a Sanofi-owned biotech firm | ...

The government’s autumn budget sends a positive signal but a more comprehensive approach is required to unlock the UK’s potential, says Graeme Moore of Mewburn Ellis.

As Donald Trump celebrates a second term, LSIPR looks at how key IP areas could be affected ahead of his return to the Oval Office. If you don't have a login or your access has expired, you will need ...